Stock Comparison

DNTH vs VRTX

Dianthus Therapeutics Inc. and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

DNTH

Dianthus Therapeutics Inc.

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$5.84B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

—

25.7

Price/Sales

3,065.7

9.9

Price/Book

5.1

6.1

EV/EBITDA

-7.2

23.2

Dividend Yield

—

Profitability

Net Margin

-847.53%

35.40%

Operating Margin

-14318.04%

38.97%

Return on Equity

-26.10%

23.50%

Return on Assets

-17.70%

11.90%

Growth (YoY)

Revenue Growth

294.30%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

0.1

0.3

52-Week High

$112.64

$529.65

52-Week Low

$20.25

$376.62

Analyst Target

$137.62

$559.28

Compare DNTH and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.